January 1-4, 2026 | Location to be Determined
Scientific Organizers:
Julia TCW, Christian Haass and Emma Mead
January 1-4, 2026 | Location to be Determined
Scientific Organizers:
Julia TCW, Christian Haass and Emma Mead
Important Deadlines
Meeting Summary
Neurodegenerative disorders are a leading cause of disability and the second leading cause of death, therefore disease modifying therapeutics and biomarkers for early diagnosis and monitoring of target engagement during treatment are desperately required. Neurodegenerative diseases share many disease overarching mechanisms. These not only include the deposition of insoluble prion-like proteins but also strong non-neuronal contributions. Vascular and neuro-immunological risk factors are described for numerous neurodegenerative disorders. Moreover, peripheral modifiers of disease progression have been identified. A systemic view of neurodegeneration, which includes all non-neuronal brain cells and influences from peripheral organs, will open new avenues for the identification of diagnostic biomarkers and targeted disease overarching interventions. The conference will therefore cover a broad spectrum of neurodegenerative disorders and include targeted sessions to discuss system-wide mechanistic research and the exciting possibility to identify unexpected disease overarching therapeutic targets.
SPECIAL RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR SPONSOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
KEYSTONE SYMPOSIA THANKS OUR MEETING EXHIBITOR(S):
KEYSTONE SYMPOSIA THANKS THESE DONOR(S) FOR GENEROUSLY SUPPORTING THIS MEETING:
THESE COMPANIES HAVE GENEROUSLY AGREED TO COVER THE EXPENSES OF THEIR EMPLOYEES WHO ARE SPEAKING AT THIS MEETING:
GRANT RECOGNITION:
KEYSTONE SYMPOSIA THANKS OUR GIFT-IN-KIND MEDIA SPONSORS
Subscribe for Updates